Global Proliferative Diabetic Retinopathy (PDR) Market Projected to Surpass $4.02 Billion by 2029 with 10.5% Annual Growth

What Are the Market Size and Growth Forecast for the Proliferative Diabetic Retinopathy (PDR) Market?
The proliferative diabetic retinopathy (PDR) market has expanded rapidly in recent years. It will grow from $2.42 billion in 2024 to $2.7 billion in 2025, at a CAGR of 11.6%. This growth is attributed to the rising prevalence of diabetes, lifestyle changes, unhealthy food intake, government initiatives, and increasing cases of diabetes-related vision loss.

The proliferative diabetic retinopathy (PDR) market is expected to experience rapid growth over the next few years, reaching $4.02 billion by 2029, at a CAGR of 10.5%. Growth drivers include an aging population, increased public awareness and education about diabetes, greater funding for research and development, and a rising demand for combination therapies. Key trends in the forecast period include advancements in diagnostic technologies, new treatment innovations, the use of artificial intelligence (AI) for early diagnosis, advancements in gene therapy, and improvements in retinal imaging.

What Is Contributing to the Growth of the Proliferative Diabetic Retinopathy (PDR) Market?
The increasing incidence of diabetes is projected to drive the growth of the proliferative diabetic retinopathy (PDR) market. Diabetes is a chronic condition characterized by elevated blood sugar levels and is the leading cause of proliferative diabetic retinopathy, a disease that can be managed through treatments aimed at preventing further retinal damage and preserving vision. For example, in June 2024, the National Health Service (NHS), a UK-based government organization, reported a rise in diabetes cases among individuals under 40, increasing from 173,166 in 2022 to 216,440 in 2023. This significant surge highlights a concerning trend in younger populations. As a result, the increasing prevalence of diabetes is fueling the growth of the proliferative diabetic retinopathy (PDR) market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12911&type=smp

Which Key Market Leaders Are Driving Proliferative Diabetic Retinopathy (PDR) Industry Growth?
Major companies operating in the proliferative diabetic retinopathy (pdr) market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, GSK PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Merck KGaA, Kubota Vision Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Santen Pharmaceutical Co. Ltd., Lupin Limited, Genentech Inc., Sirnaomics Inc.

What Are the Emerging Trends in the Proliferative Diabetic Retinopathy (PDR) Industry?
Major companies in the proliferative diabetic retinopathy market are continuously working on innovative therapies to improve treatment efficacy, minimize patient burden, and enhance outcomes. For instance, in June 2022, Biogen, a US-based biotechnology firm, and Samsung Bioepis, a South Korean biotech company, introduced Byooviz (ranibizumab-nuna), the first ophthalmology biosimilar in the US. This biosimilar is designed to treat conditions such as diabetic macular edema, proliferative diabetic retinopathy, neovascular age-related macular degeneration (wet AMD), and choroidal neovascularization.

What Are the Main Segments in the Proliferative Diabetic Retinopathy (PDR) Market?
The proliferative diabetic retinopathy (PDR) market covered in this report is segmented -

1) By Treatment Type: Anti-VEGF (Vascular Endothelial Growth Factor) Therapy, Intraocular Steroids, Laser Surgery, Vitrectomy
2) By Mode of Administration: Injectables, Oral, Other Mode Of Administrations
3) By Application: Hospitals, Clinics, Other Applications

Subsegments:
1) By Anti-VEGF Therapy: Aflibercept, Ranibizumab, Bevacizumab
2) By Intraocular Steroids: Triamcinolone Acetonide, Dexamethasone Implant, Fluocinolone Acetonide
3) By Laser Surgery: Focal Laser Photocoagulation, Panretinal Laser Photocoagulation
4) By Vitrectomy: Pars Plana Vitrectomy, Anterior Vitrectomy

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/proliferative-diabetic-retinopathy-pdr-global-market-report

Which Geographic Area Leads the Proliferative Diabetic Retinopathy (PDR) Market?
North America was the largest region in the proliferative diabetic retinopathy market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in proliferative diabetic retinopathy (PDR) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Is Covered In The Proliferative Diabetic Retinopathy (PDR) Global Market Report?

- Market Size Analysis: Analyze the Proliferative Diabetic Retinopathy (PDR) Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Proliferative Diabetic Retinopathy (PDR) Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Proliferative Diabetic Retinopathy (PDR) Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Proliferative Diabetic Retinopathy (PDR) Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12911

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.